135 related articles for article (PubMed ID: 4718190)
1. Brain acetylcholinesterase in Parkinson's disease.
Rinne UK; Riekkinen P; Sonninen V; Laaksonen H
Acta Neurol Scand; 1973; 49(2):215-26. PubMed ID: 4718190
[No Abstract] [Full Text] [Related]
2. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Bernheimer H; Birkmayer W; Hornykiewicz O; Jellinger K; Seitelberger F
J Neurol Sci; 1973 Dec; 20(4):415-55. PubMed ID: 4272516
[No Abstract] [Full Text] [Related]
3. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V
Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
[No Abstract] [Full Text] [Related]
4. Parkinson's disease: from brain homogenate to treatment.
Hornykiewicz O
Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
[No Abstract] [Full Text] [Related]
5. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
Fahn S; Libsch LR; Cutler RW
J Neurol Sci; 1971 Dec; 14(4):427-55. PubMed ID: 5125758
[No Abstract] [Full Text] [Related]
6. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
7. Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.
Birkmayer W; Danielczyk W; Neumayer E; Riederer P
J Neural Transm; 1974; 35(2):93-116. PubMed ID: 4844103
[No Abstract] [Full Text] [Related]
8. Proceedings: Para-o-methylation of dopamine in human brain.
Ebinger G; Verheyden R
Acta Neurol Belg; 1975; 75(2):111. PubMed ID: 1155020
[No Abstract] [Full Text] [Related]
9. In vivo release of transmitters in the cat basal ganglia.
Glowinski J
Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
[TBL] [Abstract][Full Text] [Related]
10. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
Perry TL; Hansen S; Kloster M
N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
[No Abstract] [Full Text] [Related]
11. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
[TBL] [Abstract][Full Text] [Related]
12. Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study.
McGeer PL; McGeer EG; Fibiger HC
Neurology; 1973 Sep; 23(9):912-7. PubMed ID: 4146891
[No Abstract] [Full Text] [Related]
13. Cerebral catecholamines after levodopa therapy.
Greer M; Collins GH; Anton AH
Arch Neurol; 1971 Nov; 25(5):461-7. PubMed ID: 5110888
[No Abstract] [Full Text] [Related]
14. L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy.
Lloyd KG; Hornykiewicz O
Nature; 1973 Jun; 243(5409):521-3. PubMed ID: 4743649
[No Abstract] [Full Text] [Related]
15. Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.
McGeer PL; McGeer EG; Wada JA; Jung E
Brain Res; 1971 Sep; 32(2):425-31. PubMed ID: 4944072
[No Abstract] [Full Text] [Related]
16. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
[No Abstract] [Full Text] [Related]
17. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi F; Fornai F; Blandini F
Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
[No Abstract] [Full Text] [Related]
18. The metabolism of brain dopamine in human parkinsonism.
Hornykiewicz O
Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
[No Abstract] [Full Text] [Related]
19. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
Hornykiewicz O
J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
[No Abstract] [Full Text] [Related]
20. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
Cobb WS; Abercrombie ED
Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
